13F COMBINATION REPORT
DC Funds, LP
Quarter ended Q1 2025 · Filed May 14, 2025 · Accession 0001398344-25-009329
Total Value
$2.1M
Positions
3
Other Managers
0
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | TSCAN THERAPEUTICS INC COM | TCRX | 630,000 | $869,400 | 42.07% |
| 2 | BARINTHUS BIOTHERAPEUTICS | BRNS | 642,204 | $624,672 | 30.22% |
| 3 | WEREWOLF THERAPEUTICS INC COM | HOWL | 589,102 | $572,725 | 27.71% |